February 28, 2018 / 11:11 AM / 6 months ago

BRIEF-Bayer Disagrees With EFSA’S Updated Risk Assessment Conclusions For Imidacloprid And Clothianidin‍​

Feb 28 (Reuters) - BAYER AG:

* BAYER -FUNDAMENTALLY DISAGREES WITH EFSA’S UPDATED RISK ASSESSMENT CONCLUSIONS FOR ACTIVE SUBSTANCES IMIDACLOPRID AND CLOTHIANIDIN‍​

* BAYER - WILL CONTINUE TO WORK WITH FARMERS, BEEKEEPERS AND REGULATORS ON SOLUTIONS THAT HAVE POSITIVE IMPACT ON BEE HEALTH Source text - bit.ly/2oBjpL1 Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below